Advertisement

Lymphoid Neoplasia

  • The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
    Ian W. Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine S. Tam, Zoltán Gasztonyi, Fritz Offner, Scott Lunin, Francesco Bosch, Matthew S. Davids, Nicole Lamanna, Ulrich Jaeger, Paolo Ghia, Florence Cymbalista, Craig A. Portell, Alan P. Skarbnik, Amanda F. Cashen, David T. Weaver, Virginia M. Kelly, Barry Turnbull and Stephan Stilgenbauer
  • Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
    Aurore Perrot, Valerie Lauwers-Cances, Jill Corre, Nelly Robillard, Cyrille Hulin, Marie-Lorraine Chretien, Thomas Dejoie, Sabrina Maheo, Anne-Marie Stoppa, Brigitte Pegourie, Lionel Karlin, Laurent Garderet, Bertrand Arnulf, Chantal Doyen, Nathalie Meuleman, Bruno Royer, Jean-Richard Eveillard, Lotfi Benboubker, Mamoun Dib, Olivier Decaux, Arnaud Jaccard, Karim Belhadj, Sabine Brechignac, Brigitte Kolb, Cecile Fohrer, Mohamad Mohty, Margaret Macro, Paul G. Richardson, Victoria Carlton, Martin Moorhead, Tom Willis, Malek Faham, Kenneth C. Anderson, Jean-Luc Harousseau, Xavier Leleu, Thierry Facon, Philippe Moreau, Michel Attal, Hervé Avet-Loiseau and Nikhil Munshi
  • Subclonal TP53 copy number is associated with prognosis in multiple myeloma
    Vallari Shah, David C. Johnson, Amy L. Sherborne, Sidra Ellis, Frances M. Aldridge, Julie Howard-Reeves, Farzana Begum, Amy Price, Jack Kendall, Laura Chiecchio, Suvi Savola, Matthew W. Jenner, Mark T. Drayson, Roger G. Owen, Walter M. Gregory, Gareth J. Morgan, Faith E. Davies, Richard S. Houlston, Gordon Cook, David A. Cairns, Graham Jackson and Martin F. Kaiser
  • FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia
    Jingliao Zhang, Yingchi Zhang, Man Zhang, Chao Liu, Xiaoming Liu, Jie Yin, Peng Wu, Xiaojuan Chen, Wenyu Yang, Li Zhang, Ye Guo, Yao Zou, Yumei Chen, Youjia Cao, Tao Cheng and Xiaofan Zhu
  • Mixed-phenotype acute leukemia, T/megakaryoblastic
    Matthew M. Klairmont and John Kim Choi
  • Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia
    Gabriel Bretones, Miguel G. Álvarez, Javier R. Arango, David Rodríguez, Ferran Nadeu, Miguel A. Prado, Rafael Valdés-Mas, Diana A. Puente, Joao A. Paulo, Julio Delgado, Neus Villamor, Armando López-Guillermo, Daniel J. Finley, Steven P. Gygi, Elías Campo, Víctor Quesada and Carlos López-Otín
  • EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation
    Lauren P. McLaughlin, Rayne Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng-Fen Wu, Fahmida Hoq, Bambi Grilley, Andrea M. Marcogliese, Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop and Catherine M. Bollard
  • Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens
    Anja Mottok, George Wright, Andreas Rosenwald, German Ott, Colleen Ramsower, Elias Campo, Rita M. Braziel, Jan Delabie, Dennis D. Weisenburger, Joo Y. Song, Wing C. Chan, James R. Cook, Kai Fu, Tim Greiner, Erlend Smeland, Harald Holte, Kerry J. Savage, Betty J. Glinsmann-Gibson, Randy D. Gascoyne, Louis M. Staudt, Elaine S. Jaffe, Joseph M. Connors, David W. Scott, Christian Steidl and Lisa M. Rimsza
  • miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
    Katerina Musilova, Jan Devan, Katerina Cerna, Vaclav Seda, Gabriela Pavlasova, Sonali Sharma, Jan Oppelt, Robert Pytlik, Vit Prochazka, Zuzana Prouzova, Martin Trbusek, Lenka Zlamalikova, Kvetoslava Liskova, Lenka Kruzova, Marie Jarosova, Andrea Mareckova, Christoph Kornauth, Ingrid Simonitsch-Klupp, Ana-Iris Schiefer, Olaf Merkel, Heidi Mocikova, Pavel Burda, Katerina Machova Polakova, Leos Kren, Jiri Mayer, Clive S. Zent, Marek Trneny, Andrew G. Evans, Andrea Janikova and Marek Mraz
  • IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
    Rabea Wagener, Cristina López, Kortine Kleinheinz, Julia Bausinger, Sietse M. Aukema, Inga Nagel, Umut H. Toprak, Julian Seufert, Janine Altmüller, Holger Thiele, Christof Schneider, Julia Kolarova, Jeongbin Park, Daniel Hübschmann, Eva M. Murga Penas, Hans G. Drexler, Andishe Attarbaschi, Randi Hovland, Eigil Kjeldsen, Michael Kneba, Udo Kontny, Laurence de Leval, Peter Nürnberg, Ilske Oschlies, David Oscier, Brigitte Schlegelberger, Stephan Stilgenbauer, Wilhelm Wössmann, Matthias Schlesner, Birgit Burkhardt, Wolfram Klapper, Elaine S. Jaffe, Ralf Küppers and Reiner Siebert

Pages